knowledge -WSS

knowledge

author：fashion 2025-09-30 11:58:40 - browse：86883

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Why Charlie Gard's case is so disturbing to Americans

WSS

VC firm General Catalyst wants to buy a health system

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Phenylephrine and the overlooked value of the placebo effect

Elisabeth Bik tackles the widespread issue of research misconduct

CDC panel: People 65 and older should get a Covid spring booster shot

3 questions for the future of Biden's cancer moonshot

hotspot

knowledge

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cholera vaccine supplies dangerously low, outbreaks surging

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA authorizes Novavax’s updated Covid

Novavax promises a turnaround & Lilly roils the obesity market

NEJM study measures Covid brain fog, impact on IQ

Medical records are filled with copy

Why age limits for politicians are a terrible idea

Bright Health sells Medicare Advantage business to Molina

Using force crossed my mind when examining a defiant young patient

entertainment

Neuroscience renaissance leads to new crop of psychiatric drugs

AI can decode, harness the power of the humane immune system

Medicare isn't yet testing food as medicine

FDA panel signals lack of confidence in Amgen cancer drug data

Neuroscience renaissance leads to new crop of psychiatric drugs

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

explore

leisure time

explore

focus